93. 原発性胆汁性胆管炎 Primary biliary cholangitis Clinical trials / Disease details
臨床試験数 : 298 / 薬物数 : 252 - (DrugBank : 59) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 115
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02557360 (ClinicalTrials.gov) | November 2015 | 21/9/2015 | Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis | Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis | Primary Biliary Cirrhosis | Dietary Supplement: S-adenosyl-L-methionine | Pomeranian Medical University Szczecin | Laval University | Completed | N/A | N/A | All | 24 | Phase 4 | Poland |
| 2 | NCT00125281 (ClinicalTrials.gov) | July 25, 2005 | 29/7/2005 | SAMe to Treat Biliary Cirrhosis Symptoms | S-Adenosyl Methionine for Symptomatic Treatment of Primary Biliary Cirrhosis | Liver Cirrhosis, Biliary | Drug: S-adenosyl-methionine (SAMe) capsules | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | NULL | Terminated | 21 Years | N/A | All | 50 | Phase 2 | United States |